[Calcitonin gene-related peptide: a key player neuropeptide in migraine].

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Revista de neurología (Ed. impresa)

• Publication date

  2016-11-16

• Fields of study

  Medicine

• Identifiers
  PMID 27819404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.

  2016cited by this paper
• Calcitonin gene-related peptide and migraine.

  2015cited by this paper
• CGRP as a neuropeptide in migraine: lessons from mice

  2015cited by this paper
• Therapeutic antibodies against CGRP or its receptor.

  2015cited by this paper
• CGRP antibodies: the Holy Grail for migraine prevention?

  2015cited by this paper
• Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

  2015cited by this paper
• CGRP Mechanism Antagonists and Migraine Management

  2015cited by this paper
• Calcitonin gene-related peptide (CGRP): a new target for migraine.

  2015cited by this paper
• Calcitonin gene‐related peptide: key regulator of cutaneous immunity

  2015cited by this paper
• Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

  2015cited by this paper
• Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity

  2014cited by this paper
• Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

  2014cited by this paper
• Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.

  2014cited by this paper
• BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial

  2014cited by this paper
• Calcitonin gene-related peptide: physiology and pathophysiology.

  2014cited by this paper
• Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

  2014cited by this paper
• Reactive Oxygen Species Induce Procalcitonin Expression in Trigeminal Ganglia Glia

  2014cited by this paper
• Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

  2013cited by this paper
• Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain

  2013cited by this paper
• Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system.

  2013cited by this paper
• Calcitonin Gene-Related Peptide Receptor Antagonists: Beyond Migraine Pain—A Possible Analgesic Strategy for Osteoarthritis?

  2013cited by this paper
• Unanswered Questions in Headache: So What Is Photophobia, Anyway?

  2013cited by this paper
• Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine

  2012cited by this paper
• Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

  2012cited by this paper
• Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine Pathophysiology

  2012cited by this paper
• Critical role of calcitonin gene-related peptide receptors in cortical spreading depression

  2012cited by this paper
• Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: Implications for photophobia

  2012cited by this paper
• Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation

  2011cited by this paper
• Calcitonin gene-related peptide (CGRP) and its role in hypertension.

  2011cited by this paper
• BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study

  2011cited by this paper
• Calcitonin Gene‐Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine

  2011cited by this paper
• Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.

  2011cited by this paper
• Advances in understanding the mechanisms of migraine-type photophobia.

  2011cited by this paper
• Keratinocyte expression of calcitonin gene‐related peptide β: Implications for neuropathic and inflammatory pain mechanisms

  2011cited by this paper
• Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

  2011cited by this paper
• Nociceptor sensitization in pain pathogenesis

  2010cited by this paper
• Regulation of signal transduction by calcitonin gene-related peptide receptors.

  2010cited by this paper
• Calcitonin gene related peptide (CGRP)–provoked migraine-like attacks

  2010cited by this paper
• CGRP and its receptors provide new insights into migraine pathophysiology

  2010cited by this paper
• Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.

  2010cited by this paper
• Migraine Pain and Nociceptor Activation—Where Do We Stand?

  2010cited by this paper
• Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura

  2010cited by this paper
• Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74

  2010cited by this paper
• Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

  2010cited by this paper
• Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology

  2009cited by this paper
• Immunotoxicity of monoclonal antibodies

  2009cited by this paper
• Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review

  2009cited by this paper
• Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine

  2009cited by this paper
• Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.

  2009cited by this paper
• Randomized, controlled trial of telcagepant for the acute treatment of migraine

  2009cited by this paper
• The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.

  2009cited by this paper
• Pharmacology of Vanilloid Transient Receptor Potential Cation Channels

  2009cited by this paper
• Mechanisms Mediating the Enhanced Gene Transcription of P2X3 Receptor by Calcitonin Gene-related Peptide in Trigeminal Sensory Neurons*

  2008cited by this paper
• Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution

  2008cited by this paper
• Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

  2008cited by this paper
• CGRP blockers in migraine therapy: where do they act?

  2008cited by this paper
• Mast cell degranulation activates a pain pathway underlying migraine headache

  2007cited by this paper
• Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

  2007cited by this paper
• The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study.

  2007cited by this paper
• Early development of therapeutic biologics--pharmacokinetics.

  2006cited by this paper
• Differential distribution of vanilloid receptors in the primary sensory neurons projecting to the dorsal skin and muscles

  2006cited by this paper
• The role of mast cells in migraine pathophysiology.

  2005cited by this paper
• Calcitonin gene‐related peptide‐containing pathways in the rat forebrain

  2005cited by this paper
• Vascular actions of calcitonin gene-related peptide and adrenomedullin.

  2004cited by this paper
• Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia

  2004cited by this paper
• Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

  2004cited by this paper
• Identification of the Human Receptor Activity-modifying Protein 1 Domains Responsible for Agonist Binding Specificity*

  2003cited by this paper
• The neuronal versus vascular hypothesis of migraine and cortical spreading depression.

  2003cited by this paper
• International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

  2002cited by this paper
• Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists* 210

  2002cited by this paper
• Protein-Protein Interaction and Not Glycosylation Determines the Binding Selectivity of Heterodimers between the Calcitonin Receptor-like Receptor and the Receptor Activity-modifying Proteins*

  2001cited by this paper
• Evidence for increased plasma levels of calcitonin gene‐related peptide in migraine outside of attacks

  2000cited by this paper
• Calcitonin gene-related peptide-like immunoreactivity marks putative visceral sensory pathways in human brain.

  2000cited by this paper
• Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

  2000cited by this paper
• Influence of aging on peripheral nerve function and regeneration

  2000cited by this paper
• Angiotensin inhibits neurotransmission of calcitonin gene-related peptide-containing vasodilator nerves in mesenteric artery of spontaneously hypertensive rats.

  1998cited by this paper
• Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials.

  1996cited by this paper
• Detailed mapping of CGRP mRNA expression in the rat central nervous system: comparison with previous immunocytochemical findings.

  1995cited by this paper
• Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression.

  1994cited by this paper
• Pathophysiology of the migraine aura. The spreading depression theory.

  1994cited by this paper
• CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37).

  1992cited by this paper
• Isolation, purification and characterization of beta-hCGRP from human spinal cord.

  1990cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper
• Differential effect of alpha-latrotoxin on exocytosis from small synaptic vesicles and from large dense-core vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction.

  1988cited by this paper
• Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat

  1987cited by this paper
• The calcitonin-like sequence of the beta CGRP gene.

  1986cited by this paper
• Calcitonin gene-related peptide is a potent vasodilator

  1985cited by this paper
• Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide

  1983cited by this paper

• Calcitonin gene-related peptide and intermedin induce phosphorylation of p44/42 MAPK in primary human lymphatic endothelial cells in vitro

  2024cites this paper
• Endogenous calcitonin gene-related peptide deficiency exacerbates postoperative lymphedema by suppressing lymphatic capillary formation and M2 macrophage accumulation.

  2019cites this paper
• Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline

  2017cites this paper
• Tyrosine Phosphorylation of NR2B Contributes to Chronic Migraines via Increased Expression of CGRP in Rats

  2017cites this paper
• [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].

  2017cites this paper